COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,141 Articles (22,693 medRxiv, 8,448 bioRxiv)

Most recent first Previous |  Page 2687: Articles 26861-26870  | Next

Phenol-chloroform-based RNA purification for detection of SARS-CoV-2 by RT-qPCR: comparison with automated systems
Dimke, H., Larsen, S. L., Skov, M. N., Larsen, H., Hartmeyer, G. N., Moeller, J. B.
10.1101/2020.05.26.20099440 — Posted: 2020-05-27
Aerosol blocking assessment by different types of fabrics for homemade respiratory masks: spectroscopy and imaging study
Foschini, M., MONTE, A. F., Mendes, A. C., Scarabucci, R. J., Maletta, A., Giuliani, C. D., Duarte, B. A., Del-Claro, K.
10.1101/2020.05.26.20100529 — Posted: 2020-05-27
Rapid assessment of the impact of lockdown on the COVID-19 epidemic in Portugal
Ricoca Peixoto, V., Vieira, A., Aguiar, P., Carvalho, C., Thomas, D., Abrantes, A.
10.1101/2020.05.26.20098244 — Posted: 2020-05-27
Mobility-Guided Modeling of the COVID-19 Pandemic in Metro Manila
Egwolf, B., Austriaco, N.
10.1101/2020.05.26.20111617 — Posted: 2020-05-27 Discussion: Onsite
Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
Piscoya, A., Ng-Sueng, L. F., Parra del Riego, A., Cerna-Viacava, R., Pasupuleti, V., Roman, Y. M., Thota, P., White, C. M., Hernandez, A. V.
10.1101/2020.05.26.20109595 — Posted: 2020-05-27
SARS-CoV-2 genome evolution exposes early human adaptations
Wright, E. S., Lakdawala, S. S., Cooper, V. S.
10.1101/2020.05.26.117069 — Posted: 2020-05-26 Discussion: Onsite
T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis
Kalfaoglu, B., Almeida-Santos, J., Tye, C. A., Satou, Y., Ono, M.
10.1101/2020.05.26.115923 — Posted: 2020-05-26
AN IMMUNOINFORMATICS STUDY TO PREDICT EPITOPES IN THE ENVELOPE PROTEIN OF SARS-COV-2
Jakhar, R., GAKHAR, S. K.
10.1101/2020.05.26.115790 — Posted: 2020-05-26
Study of cell to cell transmission of SARS CoV 2 virus particle using gene network from micro array data
Basu, A., Sarkar, A., Maulik, U.
10.1101/2020.05.26.116780 — Posted: 2020-05-26
Simeprevir suppresses SARS-CoV-2 replication and synergizes with remdesivir
Lo, H. S., Hui, K. P. Y., Lai, H.-M., Khan, K. S., Kaur, S., Li, Z., Chan, A. K. N., Cheung, H. H.-Y., Ng, K. C., Ho, J. C. W., Che, Y. W., Ma, B., Cheung, P. M.-H., Shin, D., Wang, K., Wu, K.-P., Dikic, I., Liang, P.-H., Zuo, Z., Chan, F. K. L., Hui, D. S. C., Mok, V. C. T., Wong, K.-B., Ko, H., Aik, W. S., Chan, M. C. W., Ng, W.-L.
10.1101/2020.05.26.116020 — Posted: 2020-05-26 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).